Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
Use of NCCN distress thermometer in cancer genetics patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kennedy Aidan M, Murad Andrea M, Koeppe Erika S, Riba Michelle B, Stoffel Elena M, Jacobs Michelle F
Аннотация
PURPOSE: Distress is not routinely measured in patients undergoing cancer genetic counseling. We evaluated the use of the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT) and Problem List (PL) in an unselected population of individuals presenting to a cancer genetics clinic to determine their utility in assessing distress in this population.
METHODS: Patients presenting to one cancer genetics clinic between April 2019 and March 2020 were asked to complete the DT and PL (2019 version). New patients aged 18 or older were divided into categories of low (DT score < 4) and high distress (DT score ≥ 4), consistent with NCCN groupings for evaluation of distress. Correlates of distress were explored using Chi-square and t tests.
RESULTS: Younger age and female sex assigned at birth were associated with reporting high distress. Personal history of cancer was not associated with high distress. Worry, fatigue, and sleep disturbance were the most commonly patient-reported problems.
CONCLUSION: Findings from this study show that the DT can assist in identifying patients undergoing cancer genetic counseling who are experiencing high distress; however, research to develop a PL more specific to the concerns of the oncology genetic counseling patient population may be considered to better identify relevant patient problems.
METHODS: Patients presenting to one cancer genetics clinic between April 2019 and March 2020 were asked to complete the DT and PL (2019 version). New patients aged 18 or older were divided into categories of low (DT score < 4) and high distress (DT score ≥ 4), consistent with NCCN groupings for evaluation of distress. Correlates of distress were explored using Chi-square and t tests.
RESULTS: Younger age and female sex assigned at birth were associated with reporting high distress. Personal history of cancer was not associated with high distress. Worry, fatigue, and sleep disturbance were the most commonly patient-reported problems.
CONCLUSION: Findings from this study show that the DT can assist in identifying patients undergoing cancer genetic counseling who are experiencing high distress; however, research to develop a PL more specific to the concerns of the oncology genetic counseling patient population may be considered to better identify relevant patient problems.